Diagnostics News and Research

RSS

New study shows utility of Chronix Biomedical's serum DNA tests in MS

Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests to predict clinical status and monitor disease activity and response to treatment in multiple sclerosis. Chronix Biomedical uses proprietary technology to identify disease-specific genetic fingerprints based on the circulating DNA that is released into the bloodstream by damaged and dying cells.

6 Apr 2010

ExonHit Therapeutics obtains "Innovative Company" accreditation

ExonHit Therapeutics today announced that it has obtained the "Innovative Company" accreditation from OSEO (the French state innovation agency), in recognition of the company's cutting-edge innovations in its target sectors.

6 Apr 2010

Achievements of AFC, Abbott to be highlighted at AFC's 25th Anniversary Gala

Two events occurred in 1985 that proved pivotal in the local and national fight against AIDS: the founding of the AIDS Foundation of Chicago and the development of the first-ever diagnostic test licensed to identify HIV in the blood by Abbott.

6 Apr 2010

Rice University's nano-bio-chip 93% specific in detecting patients with premalignant lesions

The gentle touch of a lesion on the tongue or cheek with a brush can help detect oral cancer with success rates comparable to more invasive techniques, according to preliminary studies by researchers at Rice University, the University of Texas Health Science Centers at Houston and San Antonio and the University of Texas M.D. Anderson Cancer Center.

6 Apr 2010

Children's Hospitals and Clinics of Minnesota announces opening of new Cardiovascular Center

Children's Hospitals and Clinics of Minnesota is opening a new world-class Cardiovascular Center—the only one of its kind in the Upper Midwest—that integrates all pediatric cardiac services in one location. The new Cardiovascular Center reflects Children's dedication to family-centered care with all private patient rooms with the latest in technology for both the patient and care team, a state-of-the-art hybrid operating room, and 24/7 access to specially trained cardiac intensivists to ensure the best possible care for patients.

5 Apr 2010

Ingen Technologies's SMART Nasal Cannula to be featured at upcoming Las Vegas MedTrade convention

Ingen Technologies, Inc., a leading manufacturer of respiratory medical devices, recently announced today that the SMART Nasal Cannula is a featured new product at the upcoming MedTrade convention in Las Vegas from May 10 through May 13, 2010. The Las Vegas MedTrade convention is the largest home health care expo in the world. Ingen is an exhibitor and will be part of the New Product showcase at MedTrade. The SMART Nasal Cannula is the Next-Generation of cannulas that improve oxygen therapy and reduce expenditures.

5 Apr 2010

Rosetta Genomics' Philadelphia lab commences FNA cell block sample analysis with miRview squamous test

Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announced today that starting April 1, 2010 physicians are able to send FNA cell block samples to Rosetta Genomics' CLIA-certified and CAP-accredited laboratory in Philadelphia for analysis using Rosetta's miRview squamous test. FNA is a less invasive method to obtain tumor cells compared with tumor resections or biopsies.

5 Apr 2010

Invalidation of gene patents will benefit patients

Dr. Jim Evans, an expert in gene patenting and genetics policy who has led a program to educate federal judges about the intricacies of genetics and genetic policy, says the ruling by United States District Court Judge Robert Sweet that invalidated seven patents related to the BRCA 1 and BRCA 2 genes "came as a surprise to everybody. It's really quite unusual for plaintiffs to get a summary judgment."

3 Apr 2010

Nationwide Children's Hospital unveils new combined operative and diagnostic MRI suite

As technology continues to change and grow, Nationwide Children's Hospital is keeping pace by unveiling a new combined operative and diagnostic MRI suite. Unlike a fixed MRI system, this structure offers the versatility of moving between three different rooms, ultimately utilizing the machine for two needs - intraoperative MRI diagnostics and non-operative diagnostic imaging.

3 Apr 2010

Capital Region Orthopaedics to implement Allscripts EHR and Practice Management solution

Allscripts today announced that Capital Region Orthopaedics has selected the Allscripts Electronic Health Record (EHR) and Practice Management solution to automate and connect 27 physicians in six locations across the Albany area.

2 Apr 2010

Genes improperly granted patents

Some time mid last year six breast cancer patients sued reputed Myriad Genetics, a company that holds patent of two vital genes BRCA1 and BRCA2 that play a role in increasing the risk of breast and ovarian cancers. The fees that the company charges for these genetic tests is a whopping $3,000 which these women claim they cannot afford and the most important of all these women cannot get a second opinion regarding the tests since no one else does them.

1 Apr 2010

ImmunoCellular Therapeutics files Annual Report with Securities and Exchange Commission for 2009

ImmunoCellular Therapeutics announced today that it has filed its Annual Report with the Securities and Exchange Commission for the period ended December 31, 2009 on Form 10-K.

1 Apr 2010

Chi's management team to complete acquisition from Carilion Clinic

Chi Solutions, Inc. (Chi), a nationally recognized healthcare consultancy focused on diagnostic outreach program management, Lean Six Sigma, mergers and acquisitions, strategic planning, and operations improvement, announced today that its management team will complete the acquisition of the company from Carilion Clinic on April 1, 2010.

1 Apr 2010

Also in Global Health News: HIV/AIDS in Central Asia; Nigeria MDGs; Aid transparency; Maternal health in Peru

Aljazerra.net reports on the spread of HIV/AIDS throughout Central Asia along drug routes in the region. The piece examines the lack of information available to the people of Central Asia about HIV prevention strategies and a recent effort among a group of Muslim imams in Tajikistan to educate people about the disease (Andersen, 3/31).

1 Apr 2010

FDA accepts for review Abbott's novel diagnostic test for rapid detection of NGAL

A novel diagnostic test to rapidly detect neutrophil gelatinase-associated lipocalin (NGAL), an early biomarker that identifies patients at risk for acute kidney injury (AKI), has been accepted for review by the United States Food and Drug Administration. If approved, this would be the first test available for use in the United States for the detection of NGAL.

1 Apr 2010

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

31 Mar 2010

IVAX Diagnostics reports net revenue of $4.5M for quarter ended December 31, 2009

IVAX Diagnostics, Inc., a fully integrated in vitro diagnostics company, reports its financial results for the fourth quarter and full year ended December 31, 2009.

31 Mar 2010

2010 BIO International Convention to discuss issues that impact drug discovery and development

The 2010 BIO International Convention will feature a robust health and medical program highlighting the latest scientific breakthroughs and policy and business development issues that impact drug discovery and development. Hosted by the Biotechnology Industry Organization, the Convention will be held May 3-6, 2010 in Chicago, Ill. at McCormick Place.

31 Mar 2010

BioNanomatrix awarded patent covering nanochannel arrays for high-throughput macromolecular analysis

BioNanomatrix, Inc., a developer of breakthrough single-molecule genomic analysis technology, today announced the issuance of U.S. patent 7,670,770 for nanochannel arrays that enable high-throughput macromolecular analysis. Also disclosed are methods of preparing nanochannel array chips, methods of analyzing macromolecules such as entire strands of genomic DNA, and systems for implementing these methods.

31 Mar 2010

Study finds groundbreaking technology in TechniScan's Warm Bath Ultrasound promising

TechniScan, Inc.'s unique whole breast ultrasound technology, which provides a comfortable, radiation-free method for assessment of breast lesions was part of a scientific presentation at the National Consortium of Breast Centers (NCBC) conference in Las Vegas last week.

31 Mar 2010

Diagnostics News and Research

New study shows utility of Chronix Biomedical's serum DNA tests in MS

ExonHit Therapeutics obtains "Innovative Company" accreditation

Achievements of AFC, Abbott to be highlighted at AFC's 25th Anniversary Gala

Rice University's nano-bio-chip 93% specific in detecting patients with premalignant lesions

Children's Hospitals and Clinics of Minnesota announces opening of new Cardiovascular Center

Ingen Technologies's SMART Nasal Cannula to be featured at upcoming Las Vegas MedTrade convention

Rosetta Genomics' Philadelphia lab commences FNA cell block sample analysis with miRview squamous test

Invalidation of gene patents will benefit patients

Nationwide Children's Hospital unveils new combined operative and diagnostic MRI suite

Capital Region Orthopaedics to implement Allscripts EHR and Practice Management solution

Genes improperly granted patents

ImmunoCellular Therapeutics files Annual Report with Securities and Exchange Commission for 2009

Chi's management team to complete acquisition from Carilion Clinic

Also in Global Health News: HIV/AIDS in Central Asia; Nigeria MDGs; Aid transparency; Maternal health in Peru

FDA accepts for review Abbott's novel diagnostic test for rapid detection of NGAL

Rosetta Genomics reports revenues of $150,000 for full-year 2009

IVAX Diagnostics reports net revenue of $4.5M for quarter ended December 31, 2009

2010 BIO International Convention to discuss issues that impact drug discovery and development

BioNanomatrix awarded patent covering nanochannel arrays for high-throughput macromolecular analysis

Study finds groundbreaking technology in TechniScan's Warm Bath Ultrasound promising

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News